Guojian Xie

Icotinib (BPI-2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclinical studies

Fenlai Tan, Xiaoyan Shen, Dechang Wang et al. · Lung Cancer · 2011 · 133 citations

Medicine, Preclinical Studies, Receptor Tyrosine Kinase +6

Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort

Xiao Huang, Zhou Luo, Wei Liang et al. · Annals of Surgical Oncology · 2022 · 62 citations · Full text

Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors

Shaojing Hu, Guojian Xie, Don X. Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 61 citations · Full text

Medicinal Chemistry, Potent Egfr Inhibitors, Quinazoline Analogues +8

A facile synthesis of staurosporine aglycone

Guojian Xie, J. William Lown · Tetrahedron Letters · 1994 · 56 citations

Staurosporine Aglycone, Stereoselective Synthesis, Chemistry +2

Synthesis and DNA cleaving properties of hybrid molecules containing propargylic sulfones and minor groove binding lexitropsins

Guojian Xie, A. Richard Morgan, J. William Lown · Bioorganic & Medicinal Chemistry Letters · 1993 · 22 citations

Chemical Biology, Synthetic Macromolecule, Biochemistry +5